Efficacy and Safety of Avatrombopag in the Treatment of Thrombocytopenia After Haplo-HSCT

NCT06202625 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

142

Enrollment

OTHER

Sponsor class

Conditions

Thrombocytopenia
Stem Cell Transplant Complications

Interventions

DRUG: avatrombopag
DRUG: Placebo

Sponsor

Peking University People's Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]